Status | Study |
RECRUITING |
Study Name: IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) Condition: Primary Biliary Cholangitis Date: 2023-09-25 Interventions: Seladelpar 10 mg one capsule daily for up to 52 weeks |
RECRUITING |
Study Name: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis Condition: Primary Biliary Cholangitis Date: 2023-09-18 Interventions: Seladelpar 10 mg one capsule daily for up to 36 months. |
Not yet recruiting |
Study Name: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis Condition: Primary Biliary Cholangitis Date: 2017-05-11 Interventions: Drug: APD334 APD334 active treatment for 24 weeks. O |
Not yet recruiting |
Study Name: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS) Condition: Primary Biliary Cirrhosis Date: 2017-04-10 Interventions: Drug: Saroglitazar magnesium 2 mg |
Recruiting |
Study Name: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Condition: Primary Biliary Cholangitis (PBC) Date: 2017-03-28 Interventions: Drug: Elafibranor 80 mg Two co |
Recruiting |
Study Name: Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid Condition: Primary Biliary Cholangitis Date: 2017-03-24 Interventions: Drug: E6011 Intravenous admini |
Recruiting |
Study Name: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension) Condition: Primary Biliary Cirrhosis Date: 2016-11-02 Interventions: Drug: MBX-8025 5 mg Capsule Op |
Recruiting |
Study Name: Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders Condition: Primary Biliary Cirrhosis Date: 2016-10-13 Interventions: Drug: Bezafibrate Bezafibrate |
Active, not recruiting |
Study Name: The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland Condition: Primary Biliary Cirrhosis Date: 2016-07-25 |
Recruiting |
Study Name: Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis Condition: Primary Biliary Cholangitis Date: 2016-06-13 Interventions: Drug: GS-9674 Tablet(s) admini |